Human GnRH-secreting cultured neurons express activin βA subunit mRNA and secrete dimeric activin A

European Journal of Endocrinology

Volumn 143, Issue 1, 2000, Pages 133-138

  Florio, P ^a   Vannelli, G B ^b   Luisi, S ^a   Barni, T ^b   Zonefrati, R ^b   Falaschi, C ^a   Bifulco, G ^c   Genazzani, A R ^a   Petraglia, F ^d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; GONADORELIN;

ARTICLE; AUTOCRINE EFFECT; GENE EXPRESSION; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; NEUROENDOCRINOLOGY; OLFACTORY EPITHELIUM; PARACRINE SIGNALING; PRIORITY JOURNAL;

EID: 0033941126     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430133     Document Type: Article

References (32)

1. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P et al. Octreotide as primary treatment for acromegaly. Journal of Clinical Endocrinology and Metabolism 1998 83 3034-5040.
2. Giusti M, Ciccarelli, E, Dallabonzana D, Delitala G, Faglia G, Liuzzi A et al. Clinical results of long-term slow-release lanreotide treatment of acromegaly. European Journal of Clinical Investigation 1997 27 277-284.
3. Lancranjan I, Atkinson B & Sandostatin LAR Group. Results of a European multicentre study with sandostatin LAR in acromegalic patients. Pituitary 1999 1 105-114.
4. Cozzi R, Dallabonzana D, Attanasio R, Barausse M & Opizzi G. A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly. European Journal of Endocrinology 1999 141 267-271.
5. Colao A, Marzullo P, Ferone D, Marino V, Pivonello C, Di Somma C et al. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly. Journal of Endocrinological Investigation 1999 22 40-47.
6. Giusti M. Area review: the use of slow-release lanreotide in the treatment of acromegalic patients. Peptide Therapy Index and Reviews 1998 10 1-17.
7. Carroll RS, Corrigan AZ, Gharib SD & Vale W. Inhibin, activin, follistatin: regulation of follicle-stimulating hormone messenger ribonucleic acid levels. Molecular Endocrinology 1989 3 1969-1973.
8. Graham KE, Nusser KD & Low MJ. LbetaT2 gonadotroph cells secrete follicle stimulating hormone (FSH) in response to active activin A. Journal of Endocrinology 1999 162 R1-R5.
9. Calogero AE, Burrello N, Ossino AM, Polosa P & D'Agata R. Activin A stimulates hypothalamic gonadotropin-releasing hormone release by the explanted male rat hypothalamus: interaction with inhibin and androgens. Journal of Endocrinology 1998 156 269-274.
10. Fernandez-Vazquez G, Kaiser UB, Albarracin CT & Chin WW. Transcriptional activation of gonadotropin-releasing hormone receptor gene by activin A. Molecular Endocrinology 1996 10 356-366.
11. Gonzales-Manchon C, Bilezikjian LM, Corrigan AZ, Mellon PL & Vale W. Activin A modulates gonadotropin-releasing hormone secretion from a gonadotropin-releasing hormone-secreting neuronal cell line. Neuroendocrinology 1991 54 373-377.
12. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL & Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-β gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology 1996 137 3667-3673.
13. Tuuri T, Eramaa M, Hildén K & Ritvos O. The tissue distribution of activin βA- and βB-subunit and follistatin messenger ribonucleic acid suggests multiple sites of action for the activin-follistatin system during human development. Journal of Clinical Endocrinology and Metabolism 1994 78 1521-1524.
14. Roberts VJ & Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994 134 914-923.
15. Vannelli GB, Ensoli F, Zonefrati R, Kubota Y, Arcangeli A, Becchetti A et al. Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors. Journal of Neuroscience 1995 15 4382-4394.
16. Barni T, Maggi M, Fantoni G, Granchi S, Mancina R, Gulisano M et al. Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. Journal of Clinical Endocrinology and Metabolism 1999 84 4266-4273.
17. Graziadei PPC & Monti-Graziadei GA. Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory neurons. Journal of Neurocytology 1979 8 1-18.
18. Kubota YH, Sakano H, Ensoli F, Thiele CJ & Vannelli GB. Odorant receptor genes expressed in a human olfactory nuroblast cell line. Journal of Cellular Biochemistry 1994 18B 182-185.
19. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annals of Biochemistry 1987 162 156-159.
20. Lambert-Messerlian GM, Luisi S, Florio P, Mazza V, Canick JA & Petraglia F. Second trimester levels of maternal serum total total activin A and placental inhibin/activin and βA subunit messenger ribonucleic acids in Down syndrome pregnancy. European Journal of Endocrinology 1998 138 425-429.
21. Florio P, Luisi S, Viganò P, Busacca M, Fadalti M, Genazzani AR et al. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle. Human Reproduction 1998 15 2606-2611.
22. Scwanzel-Fukuda M & Pfaff DW. Origin of luteinizing hormone-releasing neurons. Nature 1989 338 161-164.
23. Wray S, Grant P & Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proceedings of the National Academy of Sciences of the USA 1989 86 8132-8136.
24. Rugarli EI, Lutz B & Kuratani SC. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nature Genetics 1993 4 19-26.
25. Rochel S & Margioris FL. Carnosine release from olfactory bulb synaptosome is calcium-dependent and depolarization-stimulated. Journal of Neurochemistry 1982 38 1505-1514.
26. Vannelli GB, Barni T, Fantoni G, Zonefrati R, Brocchi A, Marcosini E et al. Regulation of GnRH production from human fetal olfactory neuroblast in culture. XXVII National Congress of the Italian Society of Endocrinology: 1997 June 4-7: Sorrento, Italy. Journal of Endocrinological Investigation 1997 20 102 (Abstract 370).
27. MacConell LA, Widger AE, Barth-Hall S & Roberts VJ. Expression of activin and follistatin in the rat hypothalamus: anatomical association with gonadotropin-releasing hormone neurons and possible role of central activin in the regulation of luteinizing hormone release. Endocrine 1998 9 233-241.
28. Gandelman R. Gonadal hormones and sensory function. Neuroscience and Biobehavioural Reviews 1983 7 1-7.
29. Jones MA. The role of vomeronasal organ in behavioral control of reproduction. Annals of the New York Academy of Sciences 1986 474 148-157.
30. Stern K & McClintok M. Regulation of ovulation by human pheromone. Nature 1998 392 177-179.
31. Hashimoto M, Kondo S, Sakurai T, Etoh Y, Shibai H & Muramutsu M. Activin/EDF as an inhibitor of neural differentiation. Biochemical and Biophysical Research Commmunications 1990 173 195-200.
32. Shubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D & Fisher WH. Activin is a nerve cell survival molecule. Nature 1990 344 868-870.